Let’s Address Racial Inequities in Healthcare by Living Our Shared Company Values

2020 has highlighted the systemic injustice that persists due to institutional inequity in our country. As a patient-centric biopharmaceutical company, we must address the health disparities that result from this continuing inequity. The pandemic has underscored this harsh reality, as people of color, particularly African Americans, endure higher levels of illness and death than White Americans due to the COVID-19 virus.